2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
7
Obesity
5
Weight Loss
2
Infertility, Female
2
Infertility
2
Sexual Infantilism
1
Prediabetic State
1
Pancreatic Neoplasms
1
Obesity, Abdominal
1
Metabolic Syndrome
1
Insulin Resistance
1
Inflammation
1
Glucose Intolerance
1
Dyslipidemias
1
Diabetes Mellitus, Type 2
1
Craniopharyngioma
1
Combined Pituitary Hormone Deficiency
1
Cardiovascular Diseases
1
Interventions
Inositol
2
relacorilant
1
pembrolizumab
1
maltodextrin
1
Surveys and Questionnaires
1
Proton Magnetic Resonance Spectroscopy
1
Pioglitazone
1
Metformin
1
Liraglutide
1
Leuprolide
1
Inulin
1
Glucose Tolerance Test
1
Estrogens
1
Continuous Positive Airway Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glucose Intolerance
×
Liraglutide
×
Clear all
NCT03480022
2021-06-07
SAXAPCOS
Woman's
Phase 3
Completed
88 enrolled
35 charts